Furthermore, recent preclinical studies as well as a clinical trial in diffuse‐type giant cell tumor patients provided evidence that the functional blockade of CSF1R impairs tumor‐promoting functions either by decreasing total TAM number or, alternatively, by reeducating TAMs (Pyonteck et al, 2013; Ries et al, 2014). Here, CSF1R is linked to neoplasm.